 |
市場調查報告書
商品編碼
2050533
抗菌藥物市場：依藥物類別、抗菌頻譜、給藥途徑、應用、通路和地區分類Antibacterial Drugs Market, By Drug Class, By Spectrum of Activity, By Route of Administration, By Application, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計到2026年，抗菌藥物市場規模將達到492.1億美元，2033年將達到687.8億美元。預計從2026年到2033年，該市場將以4.9%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 492.1億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026年至2033年預測期間的複合年成長率： | 4.90% | 2033 年預計值： | 687.8億美元 |
抗生素（也稱為抗菌藥物）是能夠透過殺死細菌或抑制細菌生長來對抗細菌感染疾病的藥物。它們被廣泛用於治療多種感染疾病，包括肺炎、結核病、炭疽、梅毒、痲瘋病和李斯特菌病。感染疾病日益流行、製藥公司加大對抗生素研發的投入以及大量新藥研發管線等因素預計將在預測期內推動市場成長。然而，政府對新抗生素核准的嚴格監管以及抗藥性細菌的出現可能會在一定程度上抑制市場成長。
市場動態
細菌感染疾病的日益普遍、新產品的上市以及強大的在研藥物儲備預計將在預測期內推動全球抗菌藥物市場成長。根據美國疾病管制與預防中心（CDC）統計，光是2021年，美國就有超過280萬例抗藥性細菌感染疾病病例，導致超過3.5萬人死亡。這顯著增加了對有效尿道感染的需求。此外，各大公司正持續加大研發投入，以開發創新藥物。例如，2022年8月，輝瑞公司（Pfizer Inc.）的新型抗生素瑞巴坦（rerebactam）獲得美國食品藥物管理局（FDA）核准，用於治療複雜性泌尿道感染和腹腔內感染疾病。然而，新抗生素核准的嚴格監管以及日益嚴重的抗生素抗藥性等因素預計將抑制市場成長。此外，對開發噬菌體療法等替代治療方法的重視，有望在未來幾年創造有前景的商業機會。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究根據以下參數創建了全球抗菌劑市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 全球抗菌藥物市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過分析全球抗菌藥物市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 影響分析
- 主要進展
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
- 產業趨勢
第4章 全球抗菌藥物市場：依藥物類別分類，2021-2033年
- 青黴素
- 頭孢菌素
- Aminoglycosides抗生素
- 四環黴素
- 大環內酯類
- Fluoroquinolones
- 磺胺類藥物藥物
- 其他
第5章 全球抗菌藥物市場：依抗菌頻譜，2021-2033年
- 頻譜抗生素
- 窄效抗生素
第6章 全球抗菌藥物市場：依給藥途徑分類，2021-2033年
- 口服
- 外用
- 靜脈
- 其他給藥途徑
第7章 全球抗菌藥物市場：依應用領域分類，2021-2033年
- 皮膚感染疾病
- 呼吸道感染疾病
- 尿道感染
- 敗血症
- 耳部感染疾病
- 胃腸道感染疾病
- 其他用途
第8章 全球抗菌藥物市場：依通路分類，2021-2033年
- 醫院藥房
- 零售藥房
- 網路藥房
第9章 全球抗菌藥物市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Novartis International AG
- GlaxoSmithKline plc
- Sanofi
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Astellas Pharma Inc.
- Johnson & Johnson
- Amgen Inc.
- Bayer AG
- Eli Lilly and Company
- AstraZeneca plc
第11章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第12章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI177
Antibacterial Drugs Market is estimated to be valued at USD 49.21 Bn in 2026 and is expected to reach USD 68.78 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 49.21 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.90% | 2033 Value Projection: | USD 68.78 Bn |
Antibacterial drugs, also known as antibiotics, are medicines that fight bacterial infections and work by either killing or inhibiting the growth of bacteria. They are widely used for the treatment of various infections such as pneumonia, tuberculosis, anthrax, syphilis, leprosy, and listeriosis. Factors such as growth in the prevalence of infectious diseases, increasing investment by pharmaceutical companies in antibiotic research, and strong pipeline of newly developed drugs are expected to drive the market growth during the forecast period. However, stringent government regulations for the approval of new antibiotics and antibiotic resistance development may restrain the market growth to a certain extent.
Market Dynamics
Key factors, such as increasing prevalence of bacterial infections, new product launches, and strong pipeline drugs, are projected to drive the global antibacterial drugs market during the forecast period. As per Centers for Disease Control and Prevention (CDC), in 2021 alone over 2.8 million antibiotic-resistant infections occurred in the U.S. and more than 35,000 people died. This creates significant demand for effective antibacterial drugs. Furthermore, large players are continuously focusing on R&D to develop innovative drugs. For instance, in August 2022, Pfizer Inc. received USFDA approval for its new antibiotic treatment, relebactam, to treat complicated urinary tract and intra-abdominal infections. However, factors like stringent regulations for approval of new antibiotics and increasing antibiotic resistance development are anticipated to restrain the market growth. Moreover, focus on the development of alternative treatment methods like bacteriophage therapy is expected to present lucrative opportunities in the coming years.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antibacterial drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer, Abbott, Merck, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb Company, Johnson & Johnson, Sanofi, Bayer, and Novartis
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibacterial drugs market
Market Segmentation
- By Drug Class Insights (Revenue, USD Billion, 2021 - 2033)
- Penicillins
- Cephalosporins
- Aminoglycosides
- Tetracyclines
- Macrolides
- Fluoroquinolones
- Sulfonamides
- Others
- By Spectrum of Activity Insights (Revenue, USD Billion, 2021 - 2033)
- Broad-spectrum Antibiotics
- Narrow-spectrum Antibiotics
- By Route of Administration Insights (Revenue, USD Billion, 2021 - 2033)
- Oral
- Topical
- Intravenous
- Other Routes
- By Application Insights (Revenue, USD Billion, 2021 - 2033)
- Skin Infections
- Respiratory Infections
- Urinary Tract Infections
- Septicemia
- Ear Infections
- Gastrointestinal Infections
- Other Applications
- By Distribution Channel Insights (Revenue, USD Billion, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Regional Insights (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Novartis International AG
- GlaxoSmithKline plc
- Sanofi
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Astellas Pharma Inc.
- Johnson & Johnson
- Amgen Inc.
- Bayer AG
- Eli Lilly and Company
- AstraZeneca plc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Antibacterial Drugs Market, By Drug Class
- Global Antibacterial Drugs Market, By Spectrum of Activity
- Global Antibacterial Drugs Market, By Route of Administration
- Global Antibacterial Drugs Market, By Application
- Global Antibacterial Drugs Market, By Distribution Channel
- Global Antibacterial Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Antibacterial Drugs Market, By Drug Class, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Penicillins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Cephalosporins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Sulfonamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
5. Global Antibacterial Drugs Market, By Spectrum of Activity, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Broad-spectrum Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Narrow-spectrum Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
6. Global Antibacterial Drugs Market, By Route of Administration 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
7. Global Antibacterial Drugs Market, By Application, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Skin Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Septicemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Ear Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
8. Global Antibacterial Drugs Market, By Distribution Channel, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Billion)
9. Global Antibacterial Drugs Market, By Region, 2021 - 2033, Value (USD Billion)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Billion)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Billion)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Spectrum of Activity, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Spectrum of Activity, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Spectrum of Activity, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Spectrum of Activity, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Spectrum of Activity, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Billion)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Spectrum of Activity, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Route of Administration 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Billion)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Billion)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
透明抗菌薄膜市場：全球市場預測，2026-2032年抗菌修復噴霧劑市場：全球市場預測，2026-2032年含銀抗菌醫用敷料市場：全球市場預測（2026-2032年）
抗菌藥物市場規模、佔有率和成長分析：按藥物類別、抗菌頻譜、給藥途徑、應用、分銷管道、最終用戶和地區分類－2026-2033年產業預測乙醯羥肟酸市場：按劑型、等級、給藥途徑、應用、最終用戶和分銷管道分類－2026-2032年全球市場預測
全球抗菌劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）芬那利莫市場：2026-2032年全球市場預測（依作物類型、劑型、給藥途徑、最終用途產業及銷售管道分類）全球氟化藥物市場（按藥物類型、治療領域、給藥途徑、研發階段、化合物類別、最終用戶和分銷管道分類），2026-2032年預測抗菌抗病毒凝膠洗手液市場（按產品類型、配方、包裝、最終用戶和分銷管道分類），全球預測（2026-2032年）氟莫西夫鈉市場依劑型、給藥途徑、適應症、最終用戶和通路分類－2026-2032年全球預測
▼